Douglas S Ingram - Net Worth and Insider Trading

Douglas S Ingram Net Worth

The estimated net worth of Douglas S Ingram is at least $53 Million dollars as of 2024-12-28. Douglas S Ingram is the President & CEO of Sarepta Therapeutics Inc and owns about 390,307 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $47 Million. Douglas S Ingram is the President of Allergan PLC and owns about 30,101 shares of Allergan PLC (AGN) stock worth over $6 Million. Douglas S Ingram is also the Director of Relay Therapeutics Inc and owns about 25,000 shares of Relay Therapeutics Inc (RLAY) stock worth over $109,000. Besides these, Douglas S Ingram also holds Endo International PLC (ENDPQ) . Details can be seen in Douglas S Ingram's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas S Ingram has not made any transactions after 2023-11-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Douglas S Ingram

To

Douglas S Ingram Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas S Ingram owns 5 companies in total, including Relay Therapeutics Inc (RLAY) , Sarepta Therapeutics Inc (SRPT) , and Skye Bioscience Inc (SKYE) among others .

Click here to see the complete history of Douglas S Ingram’s form 4 insider trades.

Insider Ownership Summary of Douglas S Ingram

Ticker Comapny Transaction Date Type of Owner
RLAY Relay Therapeutics Inc 2020-07-20 director
SRPT Sarepta Therapeutics Inc 2023-11-03 director & President & CEO
SKYE Skye Bioscience Inc 2015-06-01 director & Vice Chairman
LIMIT LIMIT 2005-02-18 director
LIMIT LIMIT 2016-05-05 director

Douglas S Ingram Latest Holdings Summary

Douglas S Ingram currently owns a total of 4 stocks. Among these stocks, Douglas S Ingram owns 390,307 shares of Sarepta Therapeutics Inc (SRPT) as of November 3, 2023, with a value of $47 Million and a weighting of 88.9%. Douglas S Ingram owns 30,101 shares of Allergan PLC (AGN) as of February 21, 2014, with a value of $6 Million and a weighting of 10.89%. Douglas S Ingram also owns 25,000 shares of Relay Therapeutics Inc (RLAY) as of July 20, 2020, with a value of $109,000 and a weighting of 0.2%. The other 1 stocks Endo International PLC (ENDPQ) have a combined weighting of 0% among all his current holdings.

Latest Holdings of Douglas S Ingram

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2023-11-03 390,307 121.50 47,422,301
AGN Allergan PLC 2014-02-21 30,101 193.02 5,810,095
RLAY Relay Therapeutics Inc 2020-07-20 25,000 4.36 109,000
ENDPQ Endo International PLC 2016-05-05 4,890 0.00 3

Holding Weightings of Douglas S Ingram


Douglas S Ingram Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas S Ingram has made a total of 2 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 25,225 shares on November 3, 2023, which cost Douglas S Ingram around $2 Million.

According to the SEC Form 4 filings, Douglas S Ingram has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 1 shares on February 21, 2014, which brought Douglas S Ingram around $126.

According to the SEC Form 4 filings, Douglas S Ingram has made a total of 1 transactions in Relay Therapeutics Inc (RLAY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Relay Therapeutics Inc is the acquisition of 25,000 shares on July 20, 2020, which cost Douglas S Ingram around $500,000.

More details on Douglas S Ingram's insider transactions can be found in the Insider Trading History of Douglas S Ingram table.

Insider Trading History of Douglas S Ingram

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas S Ingram Trading Performance

GuruFocus tracks the stock performance after each of Douglas S Ingram's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas S Ingram is 6.11%. GuruFocus also compares Douglas S Ingram's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas S Ingram within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas S Ingram's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas S Ingram

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
5 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -3.1 LIMIT LIMIT LIMIT LIMIT LIMIT

Douglas S Ingram Ownership Network

Ownership Network List of Douglas S Ingram

No Data

Ownership Network Relation of Douglas S Ingram

Insider Network Chart

Douglas S Ingram Owned Company Details

What does Relay Therapeutics Inc do?

Who are the key executives at Relay Therapeutics Inc?

Douglas S Ingram is the director of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include director & President and CEO Sanjiv Patel , Vice President & Finance Thomas Catinazzo , and See remarks Peter Rahmer .

Relay Therapeutics Inc (RLAY) Insider Trades Summary

Over the past 18 months, Douglas S Ingram made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 131,867 shares made by Peter Rahmer , a net sale of 43,738 shares made by Thomas Catinazzo , and a net sale of 17,892 shares made by Donald A Bergstrom .

In summary, during the past 3 months, insiders sold 115,043 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 115,043 shares. During the past 18 months, 389,882 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 389,882 shares.

Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Relay Therapeutics Inc Insider Transactions

No Available Data

Douglas S Ingram Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas S Ingram. You might contact Douglas S Ingram via mailing address: 2525 Dupont Dr, Irvine Ca 92612.

Discussions on Douglas S Ingram

No discussions yet.